GABA abnormalities in schizophrenia: A methodological review of in vivo studies
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Abnormalities of GABAergic interneurons are some of the most consistent findings from post-mortem studies of schizophrenia. However, linking these molecular deficits with in vivo observations in patients – a critical goal in order to evaluate interventions that would target GABAergic deficits – presents a challenge. Explanatory models have been developed based on animal work and the emerging experimental literature in schizophrenia patients. This literature includes: neuroimaging ligands to GABA receptors, magnetic resonance spectroscopy (MRS) of GABA concentration, transcranial magnetic stimulation of cortical inhibitory circuits and pharmacologic probes of GABA receptors to dynamically challenge the GABA system, usually in combination with neuroimaging studies. Pharmacologic challenges have elicited behavioral changes, and preliminary studies of therapeutic GABAergic interventions have been conducted. This article critically reviews the evidence for GABAergic dysfunction from each of these areas. These methods remain indirect measures of GABAergic function, and a broad array of dysfunction is linked with the putative GABAergic measures, including positive symptoms, cognition, emotion, motor processing and sensory processing, covering diverse brain areas. Measures of receptor binding have not shown replicable group differences in binding, and MRS assays of GABA concentration have yielded equivocal evidence of large-scale alteration in GABA concentration. Overall, the experimental base remains sparse, and much remains to be learned about the role of GABAergic interneurons in healthy brains. Challenges with pharmacologic and functional probes show promise, and may yet enable a better characterization of GABAergic deficits in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Gray, C. M., König, P., Engel, A. K., & Singer, W. (1989) · Nature · doi:10.1038/338334a0 · Cited by 4,183 · cited 1×
“These cortical rhythms are associated with integrative cortical function (Buzsaki and Draguhn, 2004), including attention (Fries et al., 2001), working memory (Tallon-Baudry et al., 1998) and perception (Gray et al., 1989).”
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 4×
“Focusing on the PV-positive interneurons, at least two varieties are relevant for schizophrenia: Fast-spiking PV-positive basket cells (PVBC) synapse on the pyramidal cell body and dendrites in layer III, whereas chandelier cells (PVChC) synapse on the axon initial segment (AIS) of the pyramidal cells (for review, see…”
InfluentialRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Interestingly, PVBCs are associated with cortical gamma oscillations (Bartos et al., 2007; Fuchs et al., 2007; Sohal et al., 2009).”
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Interestingly, PVBCs are associated with cortical gamma oscillations (Bartos et al., 2007; Fuchs et al., 2007; Sohal et al., 2009).”
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 2×
“A critical constituent of some of these theories has been hypofunction of the excitatory Nmethyl-d-aspartic acid glutamate receptors (NMDAR; Coyle, 2004; Javitt and Zukin, 1991; Olney and Farber, 1995).”
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“…A uthor M anuscript A uthor M anuscript A uthor M anuscript GABAergic interneurons, leading to excitation of the disinhibited pyramidal cells (Homayoun and Moghaddam, 2007), accounting for observations from neuroimaging studies in humans of increased cerebral blood flow and metabolism after…”
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · cited 8×
“As mentioned above, Lewis and colleagues have also suggested that a re-setting of the excitatory/inhibitory balance occurs in conjunction with reduced layer III excitation, inferred from reduced dendritic spine density (Lewis et al., 2012).”
InfluentialLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · cited 2×
“Cognitive impairment is a prominent feature of schizophrenia, and several investigators have proposed theories linking cognitive dysfunction to GABAergic abnormalities in schizophrenia (Gonzalez-Burgos et al., 2011; Lewis et al., 2012; Lisman et al., 2008).”
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938 · cited 3×
“This reduction has been localized to parvalbumin (PV) positive interneurons (Hashimoto et al., 2003) and has been observed in the dorsolateral prefrontal cortex (dLPFC; Akbarian et al., 1995), anterior cingulate cortex (ACC; Woo et al., 2004), motor cortex (Hashimoto et al., 2008b), visual cortex…”
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript (Rudolph and Knoflach, 2011) an imperfect test of the hypothesis that these subunit selective compounds can play a role in schizophrenia therapeutics.”
Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits
Szabadics, J., Varga, C., Molnár, G., Oláh, S., Barzó, P., & Tamás, G. (2006) · Science · doi:10.1126/science.1121325 · Cited by 598
Fuchs, E. C., Zivkovic, A. R., Cunningham, M. O., Middleton, S., LeBeau, F. E. N., Bannerman, D. M., Rozov, A., Whittington, M. A., Traub, R. D., Rawlins, J. N. P., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.031 · Cited by 532
GABAergic interneuron origin of schizophrenia pathophysiology
Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., & Belforte, J. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.022 · Cited by 498 · cited 2×
“…Introduction Post-mortem studies of schizophrenia have yielded definitive evidence of GABAergic abnormalities (Akbarian and Huang, 2006; Benes, 2010; Lewis et al., 2012; Nakazawa et al., 2012), but what is not clear is how these GABAergic abnormalities cause symptoms of the illness.”
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703806104 · Cited by 483 · cited 2×
“…et al., 2003) and has been observed in the dorsolateral prefrontal cortex (dLPFC; Akbarian et al., 1995), anterior cingulate cortex (ACC; Woo et al., 2004), motor cortex (Hashimoto et al., 2008b), visual cortex (Hashimoto et al., 2008b) and hippocampus (Benes et al., 2007; Knable et al., 2004).”
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426 · cited 1×
“Furthermore, considering that GAD67 deficits have been identified in patients with bipolar disorder (Guidotti et al., 2000; Torrey et al., 2005; Woo et al., 2008), affect may be an appropriate behavioral target for a schizophrenia drug aimed at one of the α-subunits of GABARs.”
Woo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
Yoon, J. H., Maddock, R. J., Rokem, A., Silver, M. A., Minzenberg, M. J., Ragland, J. D., & Carter, C. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6158-09.2010 · Cited by 408 · cited 1×
“Reduced GABA in occipital cortex has been associated with impaired performance on visual orientation surround suppression, a GABAergic-dependent early visual process deficient in schizophrenia (Yoon et al., 2010).”
Beasley, C. L., Zhang, Z. J., Patten, I., & Reynolds, G. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01360-4 · Cited by 374 · cited 1×
“Levels of PV mRNA are also reduced in schizophrenia, and some findings show that the density of these interneurons does not differ from comparison groups (Beasley et al., 2002; Hashimoto et al., 2003; Woo et al., 1997), suggesting no loss of PV-positive inhibitory interneurons in schizophrenia.”
Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
Lodge, D. J., & Grace, A. A. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.001 · Cited by 349 · cited 2×
“…to the α-1,2,3,5 subunits, and it has been suggested that drugs with subtype selectivity, e. g. for the α-2,3 subunits (Guidotti et al., 2005; Korpi and Sinkkonen, 2006; Rudolph and Mohler, 2014) or the α-5 subunit (Lodge and Grace, 2011) may be more efficacious in treating schizophrenia.”
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · cited 6×
“Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex.”
InfluentialRudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Mao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296
Hippocampal interneurons are abnormal in schizophrenia
Konradi, C., Yang, C. K., Zimmerman, E. I., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.007 · Cited by 288
Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., & Lewis, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010052 · Cited by 283 · cited 1×
“In schizophrenia, the most replicated findings are reductions in the 67-kDa isoform of the synthetic enzyme for GABA, glutamic acid decarboxylase (GAD67; Curley et al., 2011; Guidotti et al., 2000).”
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., Zhang, X., & Costa, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2212-8 · Cited by 262 · cited 2×
“…relatively non-selectively to the α-1,2,3,5 subunits, and it has been suggested that drugs with subtype selectivity, e. g. for the α-2,3 subunits (Guidotti et al., 2005; Korpi and Sinkkonen, 2006; Rudolph and Mohler, 2014) or the α-5 subunit (Lodge and Grace, 2011) may be more efficacious in…”
Depolarizing effect of neocortical chandelier neurons
Woodruff, A. (2009) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.015.2009 · Cited by 163
Hasan, A., Nitsche, M. A., Rein, B., Schneider-Axmann, T., Guse, B., Gruber, O., Falkai, P., & Wobrock, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.017 · Cited by 156 · cited 1×
“(2008) and Hasan et al. (2011). 88 S.”
Menzies, L., Ooi, C., Kamath, S., Suckling, J., McKenna, P., Fletcher, P., Bullmore, E., & Stephenson, C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.156 · Cited by 120
Fitzgerald, P. B., Brown, T. L., Daskalakis, Z. J., & Kulkarni, J. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00002-1 · Cited by 110
Cited by
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Gonzalez-Burgos, G., Cho, R. Y., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.010 · Cited by 497
Functional hierarchy underlies preferential connectivity disturbances in schizophrenia
Yang, G. J., Murray, J. D., Wang, X.-J., Glahn, D. C., Pearlson, G. D., Repovs, G., Krystal, J. H., & Anticevic, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508436113 · Cited by 153
The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67
Self-citationNikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
Metadata
- Authors
- Taylor, S. F., & Tso, I. F.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 167
- Issue
- 1-3
- Pages
- 84-90
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2159807189
- Cited by
- 124
- References
- 36
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.